Our Mission

Our mission is to assist you to transform innovative ideas into successful cosmetics or topical pharmaceutical products to address the dermatological disorders and unmet consumer needs in skin health. Neoventech commits to partner with industrial leaders to find better ways to deliver the high quality products and services in a timely manner at a competitive cost.

Neoventech strives to be the recognized leader in topical drug and active cosmetic product development. Our dedicated R&D team has a combined of 80+ years experience in drug delivery, cosmetic and topical drug product development and their successful global commercialization, supported by the state of art R&D instruments and facility, GMP/GLP capabilities and leading industrial R&D partners.

Who We Serve

• Generic developers pursuing 505(b)(2) and topical bioequivalence pathways
• Pharma and OTC companies developing or reformulating topical products
• Emerging brands needing a concept taken to a feasible physical prototype
• Cosmetic and active skin care brands seeking pharma-grade formulation rigor

Why Neoventech

• Develop and test under one roof. We formulate your product and prove its performance, one of our specialties which helps reduce handoffs and expedite the experimental process.
• Inventor-led delivery science. Guided by a founder named on 50+ granted U.S. and international patents in topical and follicular delivery.
• Commercial pedigree. Decades developing globally marketed topical and skin care products helps us prioritize manufacturability while we create our products.
• Specialized focus on our core interest of topical and transdermal delivery systems
• GMP/GLP capabilities at the New Jersey Bioscience Center.

Decades of Expertise. Dozens of Patents. One Focused Team.

Neoventech pairs robust pharmaceutical R&D experience with a hands-on approach. Our team has spent careers at the front lines of drug engineering, and we incorporate the expertise from 80+ years of combined experience, 50+ granted U.S. and international patents, and a history spanning blockbuster consumer brands and FDA-regulated drug products into each product we release.

Founder & Chief Executive Officer: Jeffrey Wu, Ph.D.

Jeffrey Wu brings 25+ years of global R&D leadership in topical pharmaceutical and skin/hair care product development. He holds a Ph.D. in Chemical Physics from Indiana University Bloomington, with doctoral research spanning analytical chemistry and chemical physics. Before founding Neoventech, Dr. Wu led R&D programs at Johnson & Johnson that brought leading products to consumers worldwide and carried multiple drug products through FDA regulatory filings, including IND, NDA, and sNDA submissions.

He is the named inventor or co-inventor on many patents covering the following areas, allowing for the launch of safer, more effective drugs:

• Hair-follicle–targeted (follicular) drug delivery and hair growth compositions
• Polymer-based topical delivery systems for enhanced skin penetration of benefit agents
• Multi-layer and film-forming topical articles
• Galvanic / electrochemical skin treatment for acne, rosacea, and active delivery

Brand History

Neoventech’s expertise is grounded in real-world commercial success, not theory. Over a 25-year industry career, our founder contributed to the development and global commercialization of widely recognized consumer health and skin care brands, including:

• Regaine (hair regrowth)
• Nizoral (antifungal shampoo)
• Neutrogena (sunscreen, acne treatment, hair care)
• Aveeno (eczema and psoriasis lotion)
• Clean & Clear (facial care and acne treatment)

The hair-regrowth and antifungal foundations behind brands like Regaine and Nizoral connect directly to Neoventech’s specialized platform for follicular delivery platform. This commercial perspective drives us to develop and test products with a clear line of sight to manufacturability, regulatory approval, and customer needs.

Contact Us

Have a topical product challenge? Contact us to discuss your project or request a quote.